FDA/CDC
News
FDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 years
Anifrolumab, a monoclonal antibody against type 1 interferon receptor, improved overall disease activity in patients with SLE on standard therapy...
FDA/CDC
‘A few mutations away’: The threat of a vaccine-proof variant
“When we have lots of people infected, we give more chances to the virus to diversify and then adapt to selective pressures.”
FDA/CDC
FDA approves first interchangeable biosimilar insulin
The approval will allow Semglee to function like a generic drug in the market and may reduce insulin costs.
FDA/CDC
CDC calls for masks in schools, hard-hit areas, even if vaccinated
FDA/CDC
FDA okays extended-release exenatide for children with T2D
It’s the second GLP-1 receptor agonist approved for youth with type 2 diabetes, and the first once-weekly.
FDA/CDC
CDC revamps STI treatment guidelines
FDA/CDC
FDA OKs odevixibat for pruritus associated with rare liver disease
PFIC appears within the first few months of life, often leading to cirrhosis and liver failure before age 10.
FDA/CDC
FDA OKs spinal cord stimulation for diabetic neuropathy pain
FDA/CDC
FDA approves new asparaginase product for leukemia
The problem is that about 20% of patients become allergic to the standard option, asparaginase derived from Escherichia coli.
FDA/CDC
FDA warns of potential mechanical concerns with MAGEC devices
MAGEC is a surgical magnetic rod system used to treat early-onset scoliosis in children under 10 years of age.